Ameritas Investment Partners, Inc. Adma Biologics, Inc. Call Options Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ADMA
# of Institutions
319Shares Held
185MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$398 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$387 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$278 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$270 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$184 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $4.2B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...